Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats

Cancer Chemotherapy and Pharmacology

Volumn 59, Issue 4, 2007, Pages 455-460

  Saad, Sherif Y ^a   Arafah, Maha M ^b   Najjar, Tawfeeg A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Cisplatin; Mycophenolate mofetil; Nephrotoxicity; Rats

Indexed keywords

ALBUMIN; CALCIUM; CISPLATIN; CREATININE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRATE; NITRITE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM BLOOD LEVEL; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; HISTOPATHOLOGY; KIDNEY DISEASE; KIDNEY MASS; KIDNEY TUBULE CELL; KIDNEY TUBULE NECROSIS; MALE; MONONUCLEAR CELL; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; UREA BLOOD LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; CREATININE; GLUTATHIONE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LIPID PEROXIDATION; MALE; MYCOPHENOLIC ACID; NITRIC OXIDE; OSTEOPONTIN; RATS; RATS, WISTAR;

EID: 33846293297     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-006-0284-8     Document Type: Article

References (41)

1. Liu M, Chien CC, Burne-Taney M, Molls RR, Racusen LC, Colvin RB, Rabb H (2006) A pathophysiologic role for T lymphocytes in murine acute Cisplatin nephrotoxicity. J Am Soc Nephrol 17:765-774
2. Taguchi T, Nazneen A, Abid MR, Razzaque MS (2005) Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 148:107-121
3. Jo SK, Cho WY, Sung SA, Kim HK, Won NH (2005) MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int 67:458-466
4. Baek SM, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK (2003) Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 142:178-186
5. Chirino YI, Hernandez-Pando R, Pedraza-Chaverri J (2004) Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol 4:20
6. Ikari A, Nagatani Y, Tsukimoto M, Harada H, Miwa M, Takagi K (2005) Sodium-dependent glucose transporter reduces peroxynitrite and cell injury caused by cisplatin in renal tubular epithelial cells. Biochim Biophys Acta 1717:109-117
7. Tsuruya K, Tokumoto M, Ninomiya T, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Hirakata H, Iida M (2003) Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways. Am J Physiol Renal Physiol 285:F208-218
8. Ramesh G, Reeves WB (2002) TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. Clin Invest 110:835-842
9. Banas B, Luckow B, Moller M, Klier C, Nelson PJ, Schadde E, Brigl M, Halevy D, Thofer HH, Reinhart B, Schlondorff D (1999) Chemokine and chemokine receptor expression in a novel human mesangial cell line. J Am Soc Nephrol 10:2314-2322
10. Rovin B, Phan L (1998) Chemotactic factors and renal inflammation. Am J Kidney Dis 31:1065-1084
11. Mele TS, Halloran PF (2000) The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 47:215-245
12. Allison AC, Eugui EM (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47:85-118
13. Engl T, MakareviT J, Relja B, Natsheh I, Müller I, Beecken WD, Jonas D, Blaheta RA (2005) Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy. BMC Cancer 5:4
14. Bonsnes RW, Taussky HN (1945) On the colorimetric determination of creatinine by Jaffe reaction. J Biol Chem 158:581-591
15. Hallett CJ, Cook JG (1971) Reduced nicotinamide adenine dinucleotide-coupled reaction for emergency blood urea estimation. Clin Chim Acta 35:33-37
16. Wrenn HT, Feichtmeir TV (1956) The quantitation of albumin based on dye linear binding capacity. Am J Clin Pathol 26:960-968
17. Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62-71
18. Ohkawa H, Ohishi N, Yagi K (1979) Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
19. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169
20. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-71
21. Links M, Lewis C (1999) Chemoprotectants. A review of their clinical pharmacology and therapeutic efficacy. Drugs 57:293-308
22. Kuhlmann MK, Burkhardt G, Kohler H (1997) Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 12:2478-2480
23. Kintzel PE (2001) Anticancer drugs-induced kidney disorders. Drug saf 24:19-28
24. Saad SY, Najjar TAO, Alashari M (2004) Role of non-selective adenosine receptor blockade and phosphodiestrase inhibition in cisplatin-induced nephrogonadal toxicity in rats. Clin Exp Pharmacol Physiol 31:862-867
25. Huang H, Zhu L, Reid BR, Drobny GP, Hopkins PB (1995) Solution structure of a cisplatin-induced DNA inter-strand cross-link. Science 270:1842-1845
26. Ueda N, Kaushal GP, Shah SV (2000) Apoptotic mechanisms in acute renal failure. Am J Med 108:403-415
27. Ramesh G, Reeves WB (2005) p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol 289:F166-174
28. Haddad JJ (2002) The involvement of L-gamma-glutamyl-L-cysteinyl-glycine (glutathione/GSH) in the mechanism of redox signaling mediating MAPK(p38)-dependent regulation of pro-inflammatory cytokine production. Biochem Pharmacol 63:305-320
29. Tapia E, Franco M, Sanchez-Lozada LG, Soto V, Avila-Casado C, Santamaria J, Quiroz Y, Rodriguez-Iturbe B, Herrera-Acosta J (2003) Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension. Kidney Int 63:994-1002
30. Rodriguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincon J, Chavez M, Parra G, Herrera-Acosta J, Gomez-Garre D, Largo R, Egido J, Johnson RJ (2001) Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 59:2222-2232
31. Lui SL, Chan LYY, Zhang XH, Zhu W, Chan TM, Fung PCW, Lai KN (2001) Effect of mycophenolate mofetil on nitric oxide production and inducible nitric oxide synthase gene expression during renal ischaemia-reperfusion injury. Nephrol Dial Transplant 16:1577-1582
32. Senda M, Delustro B, Eugui E, Natsumeda Y (1995) Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells. Transplantation 60:1143-1148
33. Nieto E, Escudero E, Navarro E, Yanez-Mo M, Martin A, Perez de Lema G, Sanchez-Madrid F, Mampaso F (2002) Effects of mycophenolate mofetil in mercury-induced autoimmune nephritis. J Am Soc Nephrol 13:937-945
34. Iguchi S, Nishi S, Ikegame M, Hoshi K, Yoshizawa T, Kawashima H, Arakawa M, Ozawa H, Gejyo F (2004) Expression of osteopontin in cisplatin-induced tubular injury. Nephron Exp Nephrol 97:e96-105
35. Wang W, Moschan L (1999) Mycophenolic acid inhibits PDGF-induced osteopontin expression in rat mesangial cells. Transplant Proc 31:1176-1177
36. Graciano ML, Cavaglieri Rde C, Delle H, Dominguez WV, Casarini DE, Malheiros DM, Noronha IL (2004) Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 15:1805-1815
37. Ardiles LG, Ehrenfeld P, Quiroz Y, Rodriguez-Iturbe B, Herrera-Acosta J, Mezzano S, Figueroa CD (2002) Effect of mycophenolate mofetil on kallikrein expression in the kidney of 5/6 nephrectomized rats. Kidney Blood Press Res 25:289-295
38. Badid C, Vincent M, McGregor B, Melin M, Hadj-Aissa A, Veysseyre C, Hartmann DJ, Desmouliere A, Laville M (2000) Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int 58:51-61
39. Gilbert RE, Kelly DJ, Mckay T, Chadban S, Hill PA, Cooper ME, Atkins RC, Nikolic-Paterson DJ (2001) PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int 59:1324-1332
40. Park J, Ha H, Seo J, Kim MS, Kim HJ, Huh KH, Park K, Kim YS (2004) Mycophenolic acid inhibits platelet-derived growth factor-induced reactive oxygen species and nitrogen-activated protein kinase activation in rat vascular smooth muscle cells. Am J transplant 4:1982-1990
41. Ludewig D, Kosmehl H, Sommer M, Bohmer FD, Stein G (2000) PDGF receptor kinase blocker AG1295 attenuates interstitial fibrosis in rat kidney after unilateral obstruction. Cell Tissue Res 299:97-103